IHAM
RYTM icon

Integral Health Asset Management’s Rhythm Pharmaceuticals RYTM Stock Holding History

Integral Health Asset Management’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$52.2M Buy
600,000
+125,000
+26% +$12.2M 2.5% 11
2025
Q4 		$50.8M Buy
475,000
+255,000
+116% +$27M 2.52% 8
2025
Q3 		$22.2M Buy
220,000
+100,000
+83% +$9.28M 1.5% 19
2025
Q2 		$7.58M Buy
+120,000
New +$7.35M 0.69% 41
2025
Q1 		– Sell
-150,000
Closed -$8.4M – 103
2024
Q4 		$8.4M Buy
+150,000
New +$8.29M 0.72% 48

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Integral Health Asset Management's RYTM Position: Q1 2026 in Review

Integral Health Asset Management increased its Rhythm Pharmaceuticals (RYTM) stake by 26% in Q1 2026, buying an estimated $12.2M and bringing the position to 600,000 shares worth $52.2M. The position accounts for 2.5% of the portfolio, ranked #11.

Integral Health Asset Management first reported a position in RYTM in Q4 2024 and has held it in 5 quarters since. 285 funds tracked by Wall St. Rank hold RYTM as of Q1 2026.

  • Integral Health Asset Management held 600,000 shares of Rhythm Pharmaceuticals worth $52.2M as of Q1 2026.
  • Integral Health Asset Management bought 125,000 Rhythm Pharmaceuticals shares in Q1 2026, an estimated $12.2M.
  • Rhythm Pharmaceuticals made up 2.5% of Integral Health Asset Management's portfolio in Q1 2026, its #11 holding.
  • Integral Health Asset Management first reported a position in Rhythm Pharmaceuticals in Q4 2024 and has held it in 5 quarters since.
  • 285 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q1 2026.

Based on Integral Health Asset Management's 13F filing for Q1 2026, filed 15 May 2026.